Post job

Mirum Pharmaceuticals's revenue is $336.9 million.

What is Mirum Pharmaceuticals's revenue?

Mirum Pharmaceuticals's annual revenue is $336.9M. Zippia's data science team found the following key financial metrics about Mirum Pharmaceuticals after extensive research and analysis.
  • Mirum Pharmaceuticals has 113 employees, and the revenue per employee ratio is $2,981,309.
  • Mirum Pharmaceuticals's peak quarterly revenue was $99.4M in 2024(q4).
  • Mirum Pharmaceuticals peak revenue was $336.9M in 2024.
  • Mirum Pharmaceuticals annual revenue for 2023 was 186.4M, 141.85% growth from 2022.
  • Mirum Pharmaceuticals annual revenue for 2024 was 336.9M, 80.76% growth from 2023.
  • Mirum Pharmaceuticals's revenue growth from 2021 to 2024 is 1,660.31%.

On this page

Most recent quarter revenue
$99.4M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$336.9M (2024)
Company peak revenue
Revenue / employee
$3.0M
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Most recent quarter revenue
$99.4M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$336.9M (2024)
Company peak revenue
Revenue / employee
$3.0M
Company revenue / employee

Mirum Pharmaceuticals historical revenue

Mirum Pharmaceuticals's peak revenue was $336.9M in 2024. The peak quarterly revenue was $99.4M in 2024(q4).

Mirum Pharmaceuticals's revenue increased from $19.1m in 2021 to $336.9M currently. That's a 1,660.31% change in annual revenue.

Mirum Pharmaceuticals annual revenue

$337M
$270M
$202M
$135M
$67M
$0
2021
2022
2023
2024

Mirum Pharmaceuticals annual revenue over time

Fiscal year / yearMirum Pharmaceuticals revenue
2021$19.1M
2022$77.1M
2023$186.4M
2024$336.9M

Rate Mirum Pharmaceuticals' financial transparency

Zippia waving zebra

Mirum Pharmaceuticals annual growth

Mirum Pharmaceuticals saw the greatest revenue growth in 2022, when revenue increased by 302.66%.

Mirum Pharmaceuticals had the lowest revenue growth in 2022, when revenue changed by 302.66%.

Mirum Pharmaceuticals annual growth rate over time

YearMirum Pharmaceuticals growth
2022
303%
2023
142%
2024
81%

Mirum Pharmaceuticals quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$99M
$80M
$60M
$40M
$20M
$0
2021
2022
2023
2024

Mirum Pharmaceuticals quarterly growth rate over time

YearQ1Q2Q3Q4
2021-$11.0M$5.0M$3.1M
2022$12.9M$17.5M$18.8M$27.9M
2023$31.6M$37.5M$47.7M$69.6M
2024$69.2M$77.9M$90.4M$99.4M

Mirum Pharmaceuticals jobs nearby

Do you work at Mirum Pharmaceuticals?

Did Mirum Pharmaceuticals meet its revenue projections?

Mirum Pharmaceuticals financial information

CEOChristopher Peetz
IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number113
Date Founded2018
HeadquartersFoster City, California
Number of Locations1
Revenue$336.9M
Net Income-$135,665,000
Gross Proft$255.2M (2024)
Tax Rate-0.0%
Total Assets$352,906,000
TickerMIRM

Mirum Pharmaceuticals jobs you might like

Mirum Pharmaceuticals financing

Mirum Pharmaceuticals received early financing of $120.0M on 2018-11-07.

SeriesRound sizeDate
Series A$120M11/2018
Post Ipo Equity$10M12/2020

Mirum Pharmaceuticals investors

InvestorsSecurity type
Novo Holdings ASeries A
New Enterprise Associates (NEA)Series A
Pappas VenturesSeries A
Frazier Healthcare PartnersSeries A
Chiesi VenturesSeries A
Rock Springs CapitalSeries A
Deerfield Capital ManagementSeries A
RiverVest Venture Management LLCSeries A
Oberland CapitalPost Ipo Equity

Mirum Pharmaceuticals revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Mirum Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Mirum Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Mirum Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Mirum Pharmaceuticals. The data presented on this page does not represent the view of Mirum Pharmaceuticals and its employees or that of Zippia.

Mirum Pharmaceuticals may also be known as or be related to MIRUM PHARMACEUTICALS, INC., Mirum Pharmaceuticals, Mirum Pharmaceuticals Inc and Mirum Pharmaceuticals, Inc.